Home/Filings/4/0001415889-24-015369
4//SEC Filing

Reasons Bryan M. 4

Accession 0001415889-24-015369

CIK 0001557746other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:30 PM ET

Size

13.2 KB

Accession

0001415889-24-015369

Insider Transaction Report

Form 4
Period: 2024-06-01
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-01+4,66028,732 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-014,6600 total
    Common Stock (4,660 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
  • [F2]The shares underlying these restricted stock units vested on June 1, 2024.

Issuer

Aclaris Therapeutics, Inc.

CIK 0001557746

Entity typeother

Related Parties

1
  • filerCIK 0001553489

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:30 PM ET
Size
13.2 KB